Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
632.90
+12.76 (2.06%)
At close: Jun 26, 2026, 4:00 PM EDT
631.38
-1.52 (-0.24%)
After-hours: Jun 26, 2026, 7:57 PM EDT

Regeneron Pharmaceuticals Employees

Regeneron Pharmaceuticals had 15,410 employees as of December 31, 2025. The number of employees increased by 304 or 2.01% compared to the previous year.

Employees
15,410
Change (1Y)
304
Growth (1Y)
2.01%
Revenue / Employee
$968,177
Profits / Employee
$287,047
Market Cap
64.39B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202515,4103042.01%
Dec 31, 202415,1061,65612.31%
Dec 31, 202313,4501,59913.49%
Dec 31, 202211,8511,48314.30%
Dec 31, 202110,3681,24513.65%
Dec 31, 20209,1231,02312.63%
Dec 31, 20198,1007009.46%
Dec 31, 20187,4001,20019.35%
Dec 31, 20176,20080014.81%
Dec 31, 20165,4001,10025.58%
Dec 31, 20154,3001,37547.01%
Dec 31, 20142,92558525.00%
Dec 31, 20132,34039020.00%
Dec 31, 20121,95024614.44%
Dec 31, 20111,70430922.15%
Dec 31, 20101,39536635.57%
Dec 31, 20091,02911011.97%
Dec 31, 200891923734.75%
Dec 31, 200768210919.02%
Dec 31, 2006573-15-2.55%
Dec 31, 2005588-142-19.45%
Dec 31, 20047308613.35%
Dec 31, 2003644-25-3.74%
Dec 31, 20026699416.35%
Dec 31, 20015758417.11%
Dec 31, 20004915412.36%
Dec 31, 19994376617.79%
Dec 31, 199837110137.41%
Dec 31, 19972702711.11%
Dec 31, 1996243--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.